Research and Markets: Global Parkinson's Disease Market Report, 2016 with GSK, Novartis, Orion & Teva Dominating

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/qwh2pd/global) has announced the addition of the "Global Parkinson's Disease Market Report, 2016 with GSK, Novartis, Orion & Teva Dominating" report to their offering.

One of the main drivers propelling the growth of the market is the steadily growing aging population worldwide. The increasing aging population is contributing to the growth of the market. The number of patients suffering from Parkinson's disease is increasing owing to the increasing aging population both in the developing and developed nations.

Vaccine development is undergoing significant advancements in the market; special focus is given to neurodegenerative diseases such as Parkinson's disease. As the drugs used to treat patients with Parkinson's have only been able to address the symptoms, a huge unmet need lies in this region. There isn't a single drug available that can modify the course of the disease. AFFiRiS AG, an Australian pharmaceutical company, is involved in the first-ever Phase I clinical development trial for Parkinson's disease (PD01A). The vaccine targets the protein alpha-Synuclein, which is responsible for the onset of the disease. PD01A is expected to encourage disease modifying effects and not symptomatic relief.

Further, the report states that one of the major challenges faced by the market is the weak pipeline landscape. Most products in the pipeline lack molecules which can potentially achieve blockbuster status in the near future.

The key vendors dominating this space include:

  • GlaxoSmithKline plc
  • Novartis AG
  • Orion Corp.
  • Teva Pharmaceuticals Industries Ltd.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology

05. Scope of the Report

06. Market Landscape

07. Geographical Segmentation

08. Key Leading Countries

09. Rate of Incidence and Prevalence

10. Vendor Landscape

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/qwh2pd/global

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices